Finance

Lists
ORX:STO
Orexo AB
15,38 SEK
-1,41%
(-0,22) 1D
22 հլս, 17:29:49 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ORX...
Open
15,68 SEK
High
16,26 SEK
Low
14,70 SEK
Mkt. cap
540,25 մլն
Avg. vol.
36,48 հզր
Volume
44,98 հզր
P/E ratio
0,61
52-wk high
43,40 SEK
52-wk low
14,04 SEK
EPS
25,33 SEK
Shares outstanding
35,13 մլն
No. of employees
61
Open
15,68 SEK
High
16,26 SEK
Low
14,70 SEK
Mkt. cap
540,25 մլն
Avg. vol.
36,48 հզր
Volume
44,98 հզր
P/E ratio
0,61
52-wk high
43,40 SEK
52-wk low
14,04 SEK
EPS
25,33 SEK
Shares outstanding
35,13 մլն
No. of employees
61
News stories
From sources across the web
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees61
Founded1995
Headquarters-
Sector-
Websiteorexo.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
118,70 մլն
3,30 մլն
5,00 մլն
3,50 մլն
Cost of goods sold
7,10 մլն
2,60 մլն
500,00 հզր
100,00 հզր
Cost of revenue
7,10 մլն
2,60 մլն
500,00 հզր
100,00 հզր
Research and development expenses
61,70 մլն
55,60 մլն
50,10 մլն
53,40 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
71,90 մլն
28,00 մլն
37,40 մլն
58,20 մլն
Operating expense
132,51 մլն
80,70 մլն
80,20 մլն
106,50 մլն
Total operating expenses
139,61 մլն
83,30 մլն
80,70 մլն
106,60 մլն
Operating income
-20,91 մլն
-80,00 մլն
-75,70 մլն
-103,10 մլն
Other non operating income
-200,00 հզր
-200,00 հզր
-100,00 հզր
-300,00 հզր
EBT including unusual items
-32,70 մլն
-115,50 մլն
-104,20 մլն
-102,30 մլն
EBT excluding unusual items
-32,71 մլն
-93,50 մլն
-104,50 մլն
-103,00 մլն
Income tax expense
-2,90 մլն
100,00 հզր
1,00 մլն
200,00 հզր
Effective tax rate
8,87%
-0,09%
-0,96%
-0,20%
Other operating expenses
-1,09 մլն
-2,90 մլն
-7,30 մլն
-5,10 մլն
Net income
-29,80 մլն
724,80 մլն
-133,90 մլն
-100,40 մլն
Net profit margin
-25,11%
21 963,64%
-2 678,00%
-2 868,57%
Earnings per share
-
-
-
-2,53
Interest and investment income
800,00 հզր
600,00 հզր
4,40 մլն
2,00 մլն
Interest expense
-11,30 մլն
-12,20 մլն
-32,90 մլն
-
Net interest expenses
-10,50 մլն
-11,60 մլն
-28,50 մլն
2,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-9,61 մլն
-46,80 մլն
-66,90 մլն
-94,90 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more